search
Back to results

Reduction of Sperm DNA Fragmentation by Oral Ginger

Primary Purpose

Infertility

Status
Completed
Phase
Phase 2
Locations
Iran, Islamic Republic of
Study Type
Interventional
Intervention
oral administration of ginger
Placebo
Sponsored by
Royan Institute
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Infertility focused on measuring Sperm DNA damage ejaculated spermatozoa Ginger Herbal Drug Herbal medicine

Eligibility Criteria

20 Years - 50 Years (Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria:

  • men with idiopathic infertility or unexplained

Exclusion Criteria:

  • history of varicocele, genitourinary inflammation or infection
  • history of cigarette smoking.

Sites / Locations

  • Royan Institute

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

ginger

Placebo

Arm Description

The patients with infertility that underwent oral administration of ginger.

The patients with infertility that receive placebo.

Outcomes

Primary Outcome Measures

sperm DNA fragmentation
Evaluation the percent of the reduction of sperm DNA fragmentation 3 months after ginger administration.

Secondary Outcome Measures

male hormones
Evaluation the effect of ginger on male hormones 3 months after oral administration.
sperm count
Evaluation the ginger on sperm count 3 months after oral administration.
sperm motility
Evaluation the effect of ginger on sperm motility 3 months after oral administration.

Full Information

First Posted
January 8, 2014
Last Updated
January 8, 2014
Sponsor
Royan Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT02032251
Brief Title
Reduction of Sperm DNA Fragmentation by Oral Ginger
Official Title
Reduction of Sperm DNA Fragmentation by Oral Ginger (Zingiberofficinale) Extract Treatment
Study Type
Interventional

2. Study Status

Record Verification Date
October 2009
Overall Recruitment Status
Completed
Study Start Date
December 2009 (undefined)
Primary Completion Date
September 2010 (Actual)
Study Completion Date
November 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Royan Institute

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study is a randomized, double blind, controlled clinical trials assess the efficacy of the ginger oral treatment on sperm DNA fragmentation, sperm parameters and male hormones.
Detailed Description
Sperm DNA fragmentation is known to affect male fertility. Previous findings have suggested the implication of oxidative stress in the etiology of this pathological condition. The present study was designed to find out DNA fragmentation in ejaculated spermatozoa can be reduced by oral treatment with Ginger extract. 71 men with unexplained or Idiopathic infertility were randomized between a Ginger treatment (500 milligram daily for 3months) group and a placebo group. Sperm DNA fragmentation was evaluated by Terminal deoxyribonucleotidyltransferase-mediated dUTP nick-end labeling assay (TUNEL) before and after treatment. No differences in basic sperm parameters were found between the Ginger treatment and the placebo group before or after treatment. However, the percentage of DNA-fragmented spermatozoa was markedly reduced (P< .005) in the Ginger treatment group after the treatment as compared with the pretreatment values). No difference in the pretreatment and post treatment incidence of sperm DNA fragmentation was observed in the placebo group. These data show that sperm DNA damage can be efficiently treated with oral Ginger extract administered during a relatively short time period.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infertility
Keywords
Sperm DNA damage ejaculated spermatozoa Ginger Herbal Drug Herbal medicine

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
71 (Actual)

8. Arms, Groups, and Interventions

Arm Title
ginger
Arm Type
Experimental
Arm Description
The patients with infertility that underwent oral administration of ginger.
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
The patients with infertility that receive placebo.
Intervention Type
Drug
Intervention Name(s)
oral administration of ginger
Other Intervention Name(s)
Administration of herbal drug
Intervention Description
Oral administration of ginger in patients with infertility.
Intervention Type
Drug
Intervention Name(s)
Placebo
Primary Outcome Measure Information:
Title
sperm DNA fragmentation
Description
Evaluation the percent of the reduction of sperm DNA fragmentation 3 months after ginger administration.
Time Frame
3 months
Secondary Outcome Measure Information:
Title
male hormones
Description
Evaluation the effect of ginger on male hormones 3 months after oral administration.
Time Frame
3months
Title
sperm count
Description
Evaluation the ginger on sperm count 3 months after oral administration.
Time Frame
3 months
Title
sperm motility
Description
Evaluation the effect of ginger on sperm motility 3 months after oral administration.
Time Frame
3 months

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: men with idiopathic infertility or unexplained Exclusion Criteria: history of varicocele, genitourinary inflammation or infection history of cigarette smoking.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hamid Gourabi, PhD
Organizational Affiliation
Head of Royan Institute
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Ali DaliriHampa, MD
Organizational Affiliation
Department of Andrology, Reproductive Biomedicine Center, Royan Institute for Reproductive Biomedicine
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Eyed Jalil Hosseini, MD
Organizational Affiliation
Department of Andrology, Reproductive Biomedicine Center, Royan Institute for Reproductive Biomedicine
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Hani Department of Andrology, Reproductive Biomedicine Center, Roya, MSc
Organizational Affiliation
Department of Andrology, Reproductive Biomedicine Center, Royan Institute for Reproductive Biomedicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Royan Institute
City
Tehran
Country
Iran, Islamic Republic of

12. IPD Sharing Statement

Links:
URL
http://Royaninstitute.org
Description
Related Info

Learn more about this trial

Reduction of Sperm DNA Fragmentation by Oral Ginger

We'll reach out to this number within 24 hrs